Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Blood platelets and inflammation]

K Zawilska, V Izrael

    Pathologie-Biologie
    |September 1, 1973
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Clinical assessment of Optivate®, a high-purity concentrate of factor VIII with von Willebrand factor, in the management of patients with haemophilia A.

    Haemophilia : the official journal of the World Federation of Hemophilia·2011
    Same author

    Pharmacokinetics of Optivate(®), a high-purity concentrate of factor VIII with von Willebrand factor, in patients with severe haemophilia A.

    Haemophilia : the official journal of the World Federation of Hemophilia·2010
    Same author

    Registry of inherited bleeding disorders in Poland--current status and potential role of the HemoRec database.

    Haemophilia : the official journal of the World Federation of Hemophilia·2010
    Same author

    [Fluoroethylthyrosine 18F PET in the detection of brain tumours].

    Bulletin du cancer·2010
    Same author

    An open clinical study assessing the efficacy and safety of Factor IX Grifols, a high-purity Factor IX concentrate, in patients with severe haemophilia B.

    Haemophilia : the official journal of the World Federation of Hemophilia·2009
    Same author

    Pharmacokinetic study of a high-purity factor IX concentrate (Factor IX Grifols) with a 6-month follow up in previously treated patients with severe haemophilia B.

    Haemophilia : the official journal of the World Federation of Hemophilia·2009